| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.31 | 0.03 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.28 | 0.03 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.27 | 0.09 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.23 | 0.2 |